A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2011
10/26/2011	CN102224989A Water bed
10/26/2011	CN102224974A Chinese medicinal composition waist belt effectively relieving waist discomfort
10/26/2011	CN101979074B Traditional Chinese medicine for treating rheumatoid arthritis
10/26/2011	CN101926900B Pediluvium composition and preparing method thereof
10/26/2011	CN101919988B Medicine compound for curing rheumatism rheumatoid arthritis and preparation method thereof
10/26/2011	CN101856446B Chinese medicinal composition for treating costalgia
10/26/2011	CN101856440B Chinese medicinal composition for treating knee sore pain
10/26/2011	CN101851291B Heavy chain and light chain variable regions of anti-human BAFF monoclonal antibody
10/26/2011	CN101791344B Traditional Chinese medicine and preparation method thereof
10/26/2011	CN101671344B Eriosema chinense flavonoid extract and extracting method and application thereof
10/26/2011	CN101342177B Lornoxicam double-layer sustained release tablets
10/26/2011	CN101293003B Effect section of frangrant ainsliaea herb, preparation method and application thereof
10/26/2011	CN101199620B Oral administration medicated liquor for treating sprain
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044042 Thienotriazolodiazepine compound and medicinal use thereof
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8044025 Urocortin proteins and uses thereof
10/25/2011	US8043624 Compositions and methods for treatment of microbial infections
10/25/2011	CA2657355C Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
10/25/2011	CA2486380C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
10/25/2011	CA2484020C Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/25/2011	CA2460834C Matrix metalloproteinase inhibitor
10/25/2011	CA2454658C Methods for treating joint inflammation, pain, and loss of mobility
10/25/2011	CA2341601C Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
10/20/2011	WO2011130740A2 Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
10/20/2011	WO2011130390A1 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/20/2011	WO2011130342A1 FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
10/20/2011	WO2011130146A1 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
10/20/2011	WO2011129269A1 Adhesive composition for medical use, adhesive patch for medical use, and method for producing the composition
10/20/2011	WO2011127586A1 Topical treatments for pain
10/20/2011	WO2011127580A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	WO2011127543A1 Proteins that bind pi16 and uses thereof
10/20/2011	WO2011127532A1 Tethered matrix metalloproteinase inhibitor
10/20/2011	WO2011066374A3 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
10/20/2011	WO2011066371A3 Antibodies to il-6 and use thereof
10/20/2011	WO2011056871A3 Rhamnolipid mechanism
10/20/2011	WO2011034896A3 Small molecule inhibitors of the alpha4-paxillin interaction
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110257381 Pharmaceutical composition comprising chito-oligomers
10/20/2011	US20110257271 Derivatives of dimethylcurcumin
10/20/2011	US20110257269 Preventive and/or therapeutic agent for inflammatory bowel diseases
10/20/2011	US20110257243 3-phenoxymethylpyrrolidine compounds
10/20/2011	US20110257240 Stabilized statin formulations
10/20/2011	US20110257238 Heteroaryl Dihydroindolones as Kinase Inhibitors
10/20/2011	US20110257232 Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators
10/20/2011	US20110257230 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257224 Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257214 Morphinan compounds
10/20/2011	US20110257210 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257203 Inhibitors of bruton's tyrosine kinase
10/20/2011	US20110257190 Crystalline forms
10/20/2011	US20110257179 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257178 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110257176 Nitrogen heterocycle derivatives as proteasome modulators
10/20/2011	US20110257170 4-morpholino-pyrido[3,2-d]pyrimidines
10/20/2011	US20110257168 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
10/20/2011	US20110257161 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
10/20/2011	US20110257157 Thiolactams and uses thereof
10/20/2011	US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/20/2011	US20110257150 New salts
10/20/2011	US20110257138 Monoterpenes for treating respiratory tract diseases, in particular bronchopulmonary diseases
10/20/2011	US20110257137 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/20/2011	US20110257134 CO-CRYSTALS OF TRAMADOL AND NSAIDs
10/20/2011	US20110257126 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
10/20/2011	US20110257115 Method for treating rhinitis and sinusitis by rhamnolipids
10/20/2011	US20110257114 Crystalline forms of 1,6-bis [3-(3-carboxymethylphenyl)-4-(2-alpha-d-mannopyranosyl-oxy)-phenyl] hexane
10/20/2011	US20110257113 Method for Inducing a Trif-Bias
10/20/2011	US20110257110 Composition comprising a glycoside of a mono- or diacylglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257103 Compositions and methods for the treatment of sj?rgren's syndrome
10/20/2011	US20110257085 Crystal Forms of Saxagliptin and Processes for Preparing Same
10/20/2011	US20110257077 Compounds and compositions as channel activating protease inhibitors
10/20/2011	US20110256249 Hair and scalp care formulations for treating and preventing acne and related skin conditions
10/20/2011	US20110256245 Methods and compositions of cannabis extracts
10/20/2011	US20110256233 Human milk permeate compositions and methods of making and using same
10/20/2011	US20110256229 Rapid-acting pharmaceutical composition
10/20/2011	US20110256226 Opioid agonist formulations with releasable and sequestered antagonist
10/20/2011	US20110256224 Methods and compositions for targeted delivery
10/20/2011	US20110256223 Gastric retained gabapentin dosage form
10/20/2011	US20110256217 Pulsatile release compositions and methods for enhanced intestinal drug absorption
10/20/2011	US20110256186 biomaterial based on wharton's jelly from the human umbilical cord
10/20/2011	US20110256160 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256159 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256156 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256149 Antibody formulation
10/20/2011	US20110256142 Novel methods and antibodies for treating cancer
10/20/2011	US20110256134 Methods of treatment using anti-oxidized ldl antibodies
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256125 Materials and methods for improved immunoglycoproteins
10/20/2011	US20110256123 Methods and uses of leptin in immune modulation and hepatocellular carcinoma
10/20/2011	US20110256121 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
10/20/2011	US20110256117 Manufacturing and use of composite scaffolds
10/20/2011	US20110256115 Hydrosoluble [6)o-alpha-d-glcp-(1->]n-6-o-beta-d-glcp-(1->-phenolic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds
10/20/2011	US20110256096 Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
10/20/2011	US20110256091 Antibody-Targeted Cytokines for Therapy
10/20/2011	US20110256090 Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof
10/20/2011	US20110256070 Pharmaceutical compositions and methods for administering the same

1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 1272